138 related articles for article (PubMed ID: 26604854)
1. Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.
Berg JA; Schjøtt J; Fossan KO; Riedel B
Subst Abuse Rehabil; 2015; 6():131-9. PubMed ID: 26604854
[TBL] [Abstract][Full Text] [Related]
2. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
Birch MA; Couchman L; Pietromartire S; Karna T; Paton C; McAllister R; Marsh A; Flanagan RJ
J Anal Toxicol; 2013 May; 37(4):233-6. PubMed ID: 23471956
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
[TBL] [Abstract][Full Text] [Related]
4. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.
Melanson SE; Snyder ML; Jarolim P; Flood JG
J Anal Toxicol; 2012 Apr; 36(3):201-6. PubMed ID: 22417836
[TBL] [Abstract][Full Text] [Related]
5. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
Darragh A; Snyder ML; Ptolemy AS; Melanson S
Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
[TBL] [Abstract][Full Text] [Related]
6. Consumption of the Sugar Substitute Stevia Leads to Cross-Reactivity of CEDIA® Buprenorphine II Immunoassay.
Plattner S; Pavlic M; Pitterl F; Schubert B
J Anal Toxicol; 2021 Nov; 45(9):1052-1057. PubMed ID: 33104778
[TBL] [Abstract][Full Text] [Related]
7. Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine.
Shaikh S; Hull MJ; Bishop KA; Griggs DA; Long WH; Nixon AL; Flood JG
J Anal Toxicol; 2008 Jun; 32(5):339-43. PubMed ID: 18544218
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment.
Böttcher M; Beck O
J Anal Toxicol; 2005; 29(8):769-76. PubMed ID: 16356333
[TBL] [Abstract][Full Text] [Related]
9. Do all screening immunoassay positive buprenorphine samples need to be confirmed?
Saleem M; Martin H; Tolya A; Coates P
Ann Clin Biochem; 2017 Nov; 54(6):707-711. PubMed ID: 28121168
[TBL] [Abstract][Full Text] [Related]
10. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine.
Schubert B; Pitterl F; Saxl B; Pavlic M
J Anal Toxicol; 2019 Jun; 43(5):364-368. PubMed ID: 30753557
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of the CEDIA buprenorphine assay with opiates: an Austrian phenomenon?
Pavlic M; Libiseller K; Grubwieser P; Rabl W
Int J Legal Med; 2005 Nov; 119(6):378-81. PubMed ID: 15834736
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
Belsey SL; Couchman L; Flanagan RJ
J Anal Toxicol; 2014 Sep; 38(7):438-43. PubMed ID: 24925983
[TBL] [Abstract][Full Text] [Related]
13. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
Schwettmann L; Külpmann WR; Vidal C
Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens.
Cirimele V; Etienne S; Villain M; Ludes B; Kintz P
Forensic Sci Int; 2004 Jul; 143(2-3):153-6. PubMed ID: 15240036
[TBL] [Abstract][Full Text] [Related]
15. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
[TBL] [Abstract][Full Text] [Related]
16. Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays.
Spanbauer AC; Casseday S; Davoudzadeh D; Preston KL; Huestis MA
J Anal Toxicol; 2001 Oct; 25(7):515-9. PubMed ID: 11599593
[TBL] [Abstract][Full Text] [Related]
17. Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assay.
Fraser AD; Meatherall R
Ther Drug Monit; 1998 Jun; 20(3):331-4. PubMed ID: 9631932
[TBL] [Abstract][Full Text] [Related]
18. Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay.
Hull MJ; Bierer MF; Griggs DA; Long WH; Nixon AL; Flood JG
J Anal Toxicol; 2008 Sep; 32(7):516-21. PubMed ID: 18713521
[TBL] [Abstract][Full Text] [Related]
19. Application of the CEDIA 6-MAM assay to routine drugs-of-abuse screening.
George C; George S; Parmar S
J Anal Toxicol; 2002; 26(4):233-5. PubMed ID: 12054365
[TBL] [Abstract][Full Text] [Related]
20. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
